Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.
Align Technology, Inc. (ALGN) is a global leader in digital orthodontic solutions, pioneering innovations like Invisalign clear aligners and iTero intraoral scanners. This page provides official updates on corporate developments, financial performance, and advancements in digital dentistry.
Access real-time press releases, earnings reports, and strategic announcements directly from the company. Investors will find quarterly results and regulatory filings, while industry professionals can track product launches, clinical studies, and partnership agreements.
Our curated collection includes updates on:
• Financial disclosures (earnings, SEC filings)
• Product innovations (new aligner technologies, scanner enhancements)
• Strategic initiatives (global expansions, research collaborations)
• Industry recognition (awards, clinical study results)
Bookmark this page for streamlined access to ALGN's latest developments. Verify investment hypotheses or stay informed about advancements in clear aligner therapy through primary-source updates.
Align Technology (NASDAQ: ALGN) opened its 2026 Annual Research Award Program offering up to $300,000 in total funding to support clinical and scientific dental research at universities worldwide. Individual regional awards include four one-year grants up to $25,000 each for Americas, EMEA, and APAC. The program has funded approximately $3.96 million since 2010. Applications are due by 5:00 p.m. PT on March 6, 2026, and awardees will be notified by June 1, 2026.
Eligible applicants are university faculty where Invisalign or iTero is available; selections follow independent academic review and Align’s final decision.
Align Technology (NASDAQ: ALGN) announced a suite of iTero Digital Solutions innovations on October 29, 2025 that expand chairside visualization, design and production workflows to boost patient engagement and treatment conversion.
Key features include the Align Oral Health Suite, Patient Gallery, simplified Oral Health Reports with QR sharing, Invisalign Outcome Simulator Pro with Smile Video (claimed to double chairside conversion for general dentistry), expanded iTero Design Suite compatibility with many 3D printers and mills, a new mock-up workflow for single-visit dentistry, and premium training and support.
New tools are globally available subject to regional regulatory approvals; Invisalign Outcome Simulator Pro availability is limited to iTero Element Plus Series and the company cites >115,000 simulations to date.
Align Technology (NASDAQ: ALGN) announced ClinCheck Live Plan, a new ClinCheck feature that automates initial Invisalign treatment plans and returns a doctor-ready 3D plan in about 15 minutes. Built on Align’s proprietary data and algorithms and experience from >21 million Invisalign patients, the system applies a doctor’s pre-configured preferences and runs quality checks after a Flex Rx submission and iTero scan. Align says ClinCheck Live Plan can shorten planning from days to minutes, enable in‑office plan approval, and improve office efficiency and patient experience. Global roll‑out is planned to begin in Q1 2026 with training resources provided.
Align Technology (NASDAQ: ALGN), a global leader in digital orthodontics and restorative dentistry, will release its Q3 2025 financial results on Wednesday, October 29, 2025, after market close at 4:00 p.m. ET. The company will host a conference call at 4:30 p.m. ET to discuss the results.
Align Technology is known for its Invisalign® System, iTero™ intraoral scanners, and exocad™ CAD/CAM software. The company serves over 286,400 doctors globally and has treated more than 20.8 million patients with the Invisalign System over 28 years, targeting a 600 million consumer market opportunity worldwide.
Align Technology (NASDAQ:ALGN) hosted its 2025 Global Faculty Meeting, bringing together over 100 Invisalign® and iTero™-trained doctor educators for comprehensive education workshops. The event, themed "Innovate. Collaborate. Educate.," focused on Align's latest innovations, clinical evidence, and best practices for treating patients of all ages.
Key highlights include the launch of a new clinical evidence webpage featuring 800+ peer-reviewed publications, expansion of the Align Global Gallery™ to over 1,500 case studies, and the continuation of the research awards program, which has provided $4 million in grants since 2010. The meeting featured presentations on patient demand, practice growth, clinical insights, and case discussions, reinforcing Align's commitment to advancing digital orthodontics and dentistry.
Align Technology (Nasdaq: ALGN) has filed a complaint with the U.S. International Trade Commission (ITC) against Angelalign Technology for alleged patent infringement related to clear aligner products. The company is seeking both an exclusion order to prevent importation of infringing products and a cease-and-desist order to stop sales of existing products in the U.S. market.
This legal action follows previous patent infringement litigation filed in August across multiple jurisdictions including the U.S. District Court, China Intermediate People's Court, and European Unified Patent Court. The complaint alleges that Angelalign's products unauthorized incorporate Align's patented technologies.
Align Technology (NASDAQ:ALGN) hosted its 2025 Invisalign® GP Summit, bringing together over 700 doctors and practice team members for a three-day educational event. The summit showcased the latest innovations in digital orthodontics, including the Invisalign® System, iTero™ scanners, and the Align™ Digital Platform.
The event featured an Innovation Hub demonstrating new technologies like the iTero Lumina™ intraoral scanner, Invisalign® Smile Video, and Align™ X-ray Insights. Align also launched the Women's Smile Collective initiative to support women in dentistry and celebrated the milestone of 20 million Invisalign® smiles transformed.
Align Technology (NASDAQ: ALGN), a leading medical device company specializing in clear aligners and digital dentistry solutions, has announced its participation in three upcoming financial conferences in September 2025.
The company's executives, including EVP Global Finance and CFO John Morici and VP Finance Shirley Stacy, will present at the 2025 Wells Fargo Healthcare Conference (Sept 3), Morgan Stanley 23rd Annual Global Healthcare Conference (Sept 9), and Baird Global Healthcare Conference (Sept 10). All presentations will be accessible via webcast through Align's Investor Relations website.
The company has treated over 20.8 million patients with its Invisalign System and serves more than 286,400 doctor customers globally.Align Technology (NASDAQ:ALGN) has initiated patent infringement lawsuits against Angelalign Technology (6699.HK) in the United States, Europe, and China. The litigation targets alleged infringement of Align's patents covering multilayer aligner materials, treatment planning, and advanced aligner features.
Align emphasizes its significant R&D investment of over $300 million annually and approximately $2 billion since 2001. The company maintains extensive global operations, including clinical treatment planning centers across multiple countries and manufacturing facilities in Mexico, Poland, and China, supporting over 20 million Invisalign® patients treated worldwide.
FAQ
What is the current stock price of Align Technology (ALGN)?
What is the market cap of Align Technology (ALGN)?
